A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer
Title:
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer
Author:
Rixe, Olivier Franco, Sandra X. Yardley, Denise A. Johnston, Stephen R. Martin, Miguel Arun, Banu K. Letrent, Stephen P. Rugo, Hope S.